We have selected the primary monoclonal rabbit anti-human BRD4 antibody (1:200; Abcam, Cambridge, UK) according to a recent study on urothelial carcinoma of the bladder [25]. This evidence concerns the gene BRD4 and bladder transitional cell carcinoma.